Veru (VERU) Dividends Paid - Common (2010 - 2015)
Veru (VERU) posted quarterly Dividends Paid - Common of $140.0 for Q2 2015, down 99.99% year-over-year from $2.1 million in Q2 2014, and down 97.31% quarter-over-quarter from $5198.0 in Q4 2014.
Veru (VERU) Dividends Paid - Common (2010 - 2015) Analysis & Trends
Veru (VERU) has reported Dividends Paid - Common for 6 consecutive years, with $140.0 the latest figure, recorded in Q2 2015.
- In Q2 2015, Dividends Paid - Common fell 99.99% year-over-year to $140.0; the TTM figure through Sep 2015 stood at $5338.0 (down 99.91% YoY), while the FY2015 annual figure was $5338.0, down 99.91% from the prior year.
- Dividends Paid - Common retreated to $140.0 in Q2 2015 per VERU's latest filing, from $5198.0 in the prior quarter.
- Across five years, Dividends Paid - Common topped out at $4.2 million in Q2 2011 and bottomed at -$40003.0 in Q3 2014.
- Historically, Dividends Paid - Common has averaged $1.6 million across 5 years, with a median of $1.7 million in 2012.
- Annual changes were most pronounced in 2011 — Dividends Paid - Common surged 93565.27% — and 2014, when it tumbled 101.96%.
- Veru's Dividends Paid - Common stood at $1.4 million in 2011, then increased by 21.0% to $1.7 million in 2012, then increased by 17.65% to $2.0 million in 2013, then tumbled by 99.74% to $5198.0 in 2014, then plunged by 97.31% to $140.0 in 2015.
- Business Quant data shows VERU's Dividends Paid - Common at $140.0 in Q2 2015, $5198.0 in Q4 2014, and -$40003.0 in Q3 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Paid (Common) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 96.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 34.60 Mn |
| 10 | Veru | 60.85 Mn | 35.06 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2015 | 140.00 |
| Jun 30, 2015 | 140.00 |
| Dec 31, 2014 | 5,198.00 |
| Dec 31, 2014 | 5,198.00 |
| Sep 30, 2014 | -40,003.00 |
| Sep 30, 2014 | -40,003.00 |
| Jun 30, 2014 | 2.10 Mn |
| Jun 30, 2014 | 2.10 Mn |
| Dec 31, 2013 | 2.00 Mn |
| Dec 31, 2013 | 2.00 Mn |
| Sep 30, 2013 | 2.04 Mn |
| Sep 30, 2013 | 2.04 Mn |
| Jun 30, 2013 | 1.96 Mn |
| Jun 30, 2013 | 1.96 Mn |
| Mar 31, 2013 | 1.80 Mn |
| Mar 31, 2013 | 1.80 Mn |
| Dec 31, 2012 | 1.70 Mn |
| Dec 31, 2012 | 1.70 Mn |
| Sep 30, 2012 | 1.71 Mn |
| Sep 30, 2012 | 1.71 Mn |